Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SAP vs GSK✓SelectedUSD · GSKSAP vs GSK performance historyLatest closeAs of-5.28%11/18
Stock and ETF performance explorer

SAP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+196.1%
GSK return
+101.2%
Excess return
+95.0%
Maximum drawdown
-52.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.3%-1.3%-3.9%-4.8%
7D-10.0%-3.1%-6.8%-8.9%
30D-6.8%-0.9%-5.9%-6.4%
3M+0.1%-4.2%+4.3%+1.6%
6M+20.7%-1.6%+22.3%+21.0%
YTD-11.7%+2.6%-14.3%-13.9%
1Y-9.9%+6.2%-16.1%-13.4%
3Y+46.1%+55.0%-8.9%+16.0%
5Y+60.9%+42.8%+18.1%+29.9%
10Y+196.1%+102.1%+94.0%+103.0%
All+196.1%+101.2%+95.0%+103.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling